110 related articles for article (PubMed ID: 8913649)
1. Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis.
Hagiwara E; Adams EM; Plotz PH; Klinman DM
Clin Exp Rheumatol; 1996; 14(5):485-91. PubMed ID: 8913649
[TBL] [Abstract][Full Text] [Related]
2. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.
Lundberg I; Ulfgren AK; Nyberg P; Andersson U; Klareskog L
Arthritis Rheum; 1997 May; 40(5):865-74. PubMed ID: 9153548
[TBL] [Abstract][Full Text] [Related]
3. Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease.
Gono T; Kaneko H; Kawaguchi Y; Hanaoka M; Kataoka S; Kuwana M; Takagi K; Ichida H; Katsumata Y; Ota Y; Kawasumi H; Yamanaka H
Rheumatology (Oxford); 2014 Dec; 53(12):2196-203. PubMed ID: 24970922
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis.
Kanik KS; Hagiwara E; Yarboro CH; Schumacher HR; Wilder RL; Klinman DM
J Rheumatol; 1998 Jan; 25(1):16-22. PubMed ID: 9458197
[TBL] [Abstract][Full Text] [Related]
5. Features of polymyositis and dermatomyositis in the elderly: a case-control study.
Pautas E; Chérin P; Piette JC; Pelletier S; Wechsler B; Cabane J; Herson S
Clin Exp Rheumatol; 2000; 18(2):241-4. PubMed ID: 10812498
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic changes in dermatomyositis and polymyositis.
Deveza LM; Miossi R; de Souza FH; Shimabuco AY; Favarato MH; Grindler J; Shinjo SK
Rev Bras Reumatol Engl Ed; 2016; 56(2):95-100. PubMed ID: 27267520
[TBL] [Abstract][Full Text] [Related]
7. B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis.
Peng QL; Shu XM; Wang DX; Wang Y; Lu X; Wang GC
Biomark Med; 2014; 8(3):395-403. PubMed ID: 24712431
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of serum markers for the development of interstitial lung disease in patients with polymyositis and dermatomyositis: a comparative and prospective study.
Chen F; Lu X; Shu X; Peng Q; Tian X; Wang G
Intern Med J; 2015 Jun; 45(6):641-7. PubMed ID: 25827843
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic analysis of the clinical features of Japanese patients with polymyositis and dermatomyositis.
Tomimitsu H; Ohta A; Nagai M; Nishina M; Ishihara S; Kohsaka H
Mod Rheumatol; 2016; 26(3):398-402. PubMed ID: 26375202
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of venous thromboembolism in patients with dermatomyositis/polymyositis: a nationwide cohort study.
Chung WS; Lin CL; Sung FC; Lu CC; Kao CH
Thromb Res; 2014 Sep; 134(3):622-6. PubMed ID: 25034321
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor-mediated characteristic signaling pathway of peripheral blood T cells in dermatomyositis and polymyositis.
Shimojima Y; Matsuda M; Ishii W; Kishida D; Sekijima Y
Autoimmunity; 2017 Dec; 50(8):481-490. PubMed ID: 29172719
[TBL] [Abstract][Full Text] [Related]
12. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of endothelial progenitor cells is associated with the type I IFN pathway in patients with polymyositis and dermatomyositis.
Ekholm L; Kahlenberg JM; Barbasso Helmers S; Tjärnlund A; Yalavarthi S; Zhao W; Seto N; Betteridge Z; Lundberg IE; Kaplan MJ
Rheumatology (Oxford); 2016 Nov; 55(11):1987-1992. PubMed ID: 27498356
[TBL] [Abstract][Full Text] [Related]
14. Relationship between disease activity and type 1 interferon- and other cytokine-inducible gene expression in blood in dermatomyositis and polymyositis.
Greenberg SA; Higgs BW; Morehouse C; Walsh RJ; Kong SW; Brohawn P; Zhu W; Amato A; Salajegheh M; White B; Kiener PA; Jallal B; Yao Y
Genes Immun; 2012 Apr; 13(3):207-13. PubMed ID: 21881594
[TBL] [Abstract][Full Text] [Related]
15. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis.
Aleksza M; Szegedi A; Antal-Szalmás P; Irinyi B; Gergely L; Ponyi A; Hunyadi J; Sipka S; Zeher M; Szegedi G; Dankó K
Ann Rheum Dis; 2005 Oct; 64(10):1485-9. PubMed ID: 15829578
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment with etanercept significantly reduces the number of proinflammatory cytokine-secreting peripheral blood mononuclear cells in patients with rheumatoid arthritis.
Schotte H; Schlüter B; Willeke P; Mickholz E; Schorat MA; Domschke W; Gaubitz M
Rheumatology (Oxford); 2004 Aug; 43(8):960-4. PubMed ID: 15026584
[TBL] [Abstract][Full Text] [Related]
17. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
Khan S; Christopher-Stine L
Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort.
Dobloug C; Garen T; Bitter H; Stjärne J; Stenseth G; Grøvle L; Sem M; Gran JT; Molberg Ø
Ann Rheum Dis; 2015 Aug; 74(8):1551-6. PubMed ID: 24695011
[TBL] [Abstract][Full Text] [Related]
19. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.
Page G; Chevrel G; Miossec P
Arthritis Rheum; 2004 Jan; 50(1):199-208. PubMed ID: 14730617
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary involvement in polymyositis and in dermatomyositis.
Marie I; Hatron PY; Hachulla E; Wallaert B; Michon-Pasturel U; Devulder B
J Rheumatol; 1998 Jul; 25(7):1336-43. PubMed ID: 9676766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
